3rd Quarter - Report

BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$840,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 16, 2008 $840,000 Replaced
3rd Quarter - Amendment Jun 15, 2010 $840,000 Yes

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Clean Air and Water (quality) CAW

NO BILL, Pharmaceuticals in the environment. Lobbied to educate Members of Congress on the issue of pharmaceuticals in the environment

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —
CHRISTOPHER PERNIE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

H.R. 1424, The Emergency Economic Stabilization Act of 2008. Lobbied to extend the research tax credit. H.R. 6049, Energy Improvement and Extension Act of 2008. Lobbied to extend the research and development tax credit.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —
LANE PENRY —
CHRISTOPHER PERNIE —
JOHN RYAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1424 (110th), H.R. 6049 (110th)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007. Lobbied Members of Congress to improve provisions related to inequitable conduct and damages.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —
CHRISTOPHER PERNIE —
RICHARD THOMPSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1145 (110th)

Health Issues HCR

H.R. 5629/S. 1695, Biologics Price Competition & Innovation Act. Lobbied Members of Congress in support of an FDA pathway for biosimilar products, patient safety, and data exclusivity. H.R. 1424, The Paul Wellstone Mental Health and Addiction Equity Act. Lobbied Members of Congress in support of mental health parity and against increased Medicaid rebates. Labor, HHS Appropriations Bill. Lobbied to ensure patient access to HIV/AIDS medicines through ADAP S. 2731/ H.R. 5501, Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act. Lobbied Members of Congress in support of reauthorization of the Presidents Emergency Program for AIDS Relief. H.R. 5839, Safeguarding America's Pharmaceuticals Act. Lobbied to educate Members of Congress about safety of the prescription drug supply chain. H.R. 3610, Food and Drug Import Safety Act of 2007. Lobbied to ensure safety and access to prescription drugs S. 999, The STOP Stroke Act. Lobbied for passage of bill. NO BILL, Pharmaceuticals in The environment. Lobbied to educate Members of Congress on the issue of pharmaceuticals in the environment.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —
LANE PENRY —
CHRISTOPHER PERNIE —
RICHARD THOMPSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5839 (110th), H.R. 5501 (110th), S. 1695 (110th), H.R. 5629 (110th), H.R. 3610 (110th), H.R. 1424 (110th), S. 999 (110th), S. 2731 (110th)

Medicare/Medicaid MMM

S. 3101, Medicare Improvements for Patients and Providers Act of 2008. Lobby to maintain the current rebate percentage. S. 2320, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007.Lobbied for passage of bill. NO BILL, Medicare Part D Oversight. Lobbied Members of Congress to educate on the benefits of private negotiation in Medicare Part D.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —
LANE PENRY —
CHRISTOPHER PERNIE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2320 (110th), S. 3101 (110th)

Consumer Issues/Safety/Products CSP

S. 2928, BPA-Free Kids Act of 2008. Lobbied to inform Members of Congress on the safety of materials used to line cans of infant formula.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2928 (110th)

Medical/Disease Research/Clinical Labs MED

NO BILL, Cancer Research. Lobbied to support cancer research.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —
RICHARD THOMPSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Law Enforcement/Crime/Criminal Justice LAW

H.R. 6491, To amend title 18, U.S. Code, to combat, deter, and punish individuals and enterprises engaged nationally/internationally in organized crime involving theft and interstate fencing of stolen retail merchandise, and for other purposes. Lobbied in support of efforts to control retail theft via the Internet.

LobbyistCovered position, as disclosed
MICHAEL CAROZZA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6491 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.